Taken together, the above results demonstrated that FXR promotes Jak2/STAT3-mediated tumor metastasis and angiogenesis through upregulation of IL-6 and IL-6ST in NSCLC cells. The gene discussed is STAT3; the disease is non-small cell lung carcinoma.